Although the Guided Therapeutics Inc (OTCMKTS:GTHP) stock was trading within a range on Wednesday, it might still be a good idea to take a closer look at the stock considering the fact that a stock can break out after trading in a range as well.
That being said, it is also necessary to note that there has been no news about the company for several weeks and the last time any news emerged about the company was back on August 19 this year. The company, which is best known for having developed the LuViva® Advanced Cervical Scan, announced at the time that it had been successful in clearing the regulatory compliance review from the Shanghai based Department of Obstetrics & Gynecology Hospital of Fudan University.
That was a significant development for the company considering the fact that Guided Therapeutics then had the permission to start clinical trials at the establishment. In addition to that, the company was going to start clinical trials at three other centres during the course of that quarter. In addition to that, Guided Therapeutics also got a payment of as much as $133,000 from the Shandong Yaohua Medical Instrument Corporation , its co-manufacturing partner and distributor for the Chinese market.
